KD
Kevin DeGeeter Ladenburg Thalmann Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Oric Pharmaceuticals
ORIC
$1.05B
| $10.86 | $15 |
38%
upside
| Buy |
8 Jul ‘25
2 months ago |
|
2
Cardiff Oncology
CRDF
$138M
| $2.08 | $19 |
813%
upside
| Buy |
8 Jul ‘25
2 months ago |
|
3
NovoCure
NVCR
$1.42B
| $12.73 | $30 |
136%
upside
| Buy |
8 Jul ‘25
2 months ago |
|
4
AN2 Therapeutics
ANTX
$34.7M
| $1.27 | $22 |
1,632%
upside
| Outperform |
19 Apr ‘22
3 years ago |
|
5
Personalis
PSNL
$541M
| $6.10 | $24 |
293%
upside
| Outperform |
25 Feb ‘22
3 years ago |
|
|
6
NovoCure
NVCR
$1.42B
| $12.73 | $98 |
670%
upside
| Outperform |
2 Feb ‘22
3 years ago |
|
7
Fulgent Genetics
FLGT
$681M
| $22.25 | $125 |
462%
upside
| Outperform |
25 Jan ‘22
3 years ago |
|
8
MDxHealth
MDXH
$190M
| $3.83 | $18 |
370%
upside
| Outperform |
29 Nov ‘21
3 years ago |
|
9
Sera Prognostics
SERA
$117M
| $3.07 | $19 |
519%
upside
| Outperform |
19 Nov ‘21
3 years ago |
|
|
ATON
10
AlphaTON Capital Corp. Common Stock
ATON
$32.8M
| $5.45 | $600 |
10,909%
upside
| Outperform |
21 Sep ‘21
4 years ago |
|
11
Palo Alto Networks
PANW
$133B
| $198.33 | $79.17 |
60%
downside
| Outperform |
24 Aug ‘21
4 years ago |
|
12
Exact Sciences
EXAS
$10.6B
| $56.01 | $155 |
177%
upside
| Outperform |
29 Jul ‘21
4 years ago |
|
13
Rezolute
RZLT
$693M
| $7.97 | $25 |
214%
upside
| Outperform |
27 May ‘21
4 years ago |
|
14
Cyclacel Pharmaceuticals
CYCC
$14.3M
| $6.37 | $61,200 |
960,654%
upside
| Outperform |
30 Apr ‘21
4 years ago |
|
|
EVAX
15
Evaxion A/S American Depositary Share
EVAX
$18.2M
| $2.88 | $900 |
31,150%
upside
| Outperform |
2 Mar ‘21
4 years ago |
|
16
Cellectar Biosciences
CLRB
$16.9M
| $5.28 | $1,500 |
28,309%
upside
| Outperform |
1 Jul ‘20
5 years ago |
|
17
Bionano Genomics
BNGO
$19M
| $4.06 | $900 |
22,067%
upside
| Outperform |
8 Apr ‘20
5 years ago |
|